Cullinan Associates’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,000
| Closed | -$9.83M | – | 226 |
|
|
2024
Q4 | $9.83M | Hold |
30,000
| – | – | 0.63% | 40 |
|
|
2024
Q3 | $8.66M | Hold |
30,000
| – | – | 0.49% | 48 |
|
|
2024
Q2 | $9.88M | Hold |
30,000
| – | – | 0.56% | 47 |
|
|
2024
Q1 | $11.9M | Sell |
30,000
-4,000
| -12% | -$1.58M | 0.67% | 40 |
|
|
2023
Q4 | $12M | Hold |
34,000
| – | – | 0.67% | 33 |
|
|
2023
Q3 | $12.8M | Hold |
34,000
| – | – | 0.74% | 31 |
|
|
2023
Q2 | $13M | Hold |
34,000
| – | – | 0.71% | 33 |
|
|
2023
Q1 | $11.8M | Sell |
34,000
-839
| -2% | -$291K | 0.69% | 40 |
|
|
2022
Q4 | $8.2M | Buy |
34,839
+20,839
| +149% | +$4.9M | 0.45% | 50 |
|
|
2022
Q3 | $3.45M | Hold |
14,000
| – | – | 0.22% | 98 |
|
|
2022
Q2 | $4.23M | Hold |
14,000
| – | – | 0.26% | 88 |
|
|
2022
Q1 | $5.75M | Buy |
+14,000
| New | +$5.75M | 0.3% | 80 |
|